Jarrod D Predina1, Andrew D Newton2, Christopher Corbett1, Michael Shin1, Lydia Frenzel Sulfyok1, Olugbenga T Okusanya3, Edward J Delikatny4, Shuming Nie5, Colleen Gaughan1, Doraid Jarrar1, Taine Pechet1, John C Kucharczuk1, Sunil Singhal6. 1. Center for Precision Surgery, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pa; Division of Thoracic Surgery, Department of Surgery, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pa. 2. Center for Precision Surgery, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pa; Department of Surgery, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pa. 3. Department of Surgery, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pa. 4. Center for Precision Surgery, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pa. 5. Department of Chemistry, University of Illinois, Champaign, Ill. 6. Center for Precision Surgery, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pa; Division of Thoracic Surgery, Department of Surgery, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pa. Electronic address: Sunil.singhal@uphs.upenn.edu.
Abstract
BACKGROUND: Complete pulmonary metastasectomy for sarcoma metastases provides patients an opportunity for long-term survival and possible cure. Intraoperative localization of preoperatively identified metastases and identification of occult lesions can be challenging. In this trial, we evaluated the efficacy of near-infrared (NIR) intraoperative imaging using second window indocyanine green during metastasectomy to identify known metastases and to detect occult nodules. METHODS: Thirty patients with pulmonary nodules suspicious for sarcoma metastases were enrolled in an open-label, feasibility study (NCT02280954). All patients received intravenous indocyanine green (5 mg/kg) 24 hours before metastasectomy. Patients 1 through 10 (cohort 1) underwent metastasectomy via thoracotomy to assess fluorescence patterns of nodules detected by traditional methods (preoperative imaging and intraoperative visualization/bimanual palpation). After confirming reliability within cohort 1, patients 11 through 30 (cohort 2) underwent video-assisted thoracic surgery metastasectomy with NIR imaging. RESULTS: In cohort 1, 14 out of 16 preoperatively identified pulmonary metastases (87.5%) displayed tumor fluorescence. Nonfluorescent metastases were deeper than fluorescent metastases (2.1 cm vs 1.3 cm; P = .03). Five out of 5 metastases identified during thoracotomy displayed fluorescence. NIR imaging identified 3 additional occult lesions in this cohort. In cohort 2, 33 out of 37 known pulmonary metastases (89.1%) displayed fluorescence. Nonfluorescent tumors were deeper than 2.0 cm (P = .007). NIR imaging identified 24 additional occult lesions. Of 24 occult lesions, 21 (87.5%) were confirmed metastases and the remaining 3 nodules were lymphoid aggregates. CONCLUSIONS: NIR intraoperative imaging with indocyanine green (5 mg/kg and 24 hours before surgery) localizes known sarcoma pulmonary metastases and identifies otherwise occult lesions. This approach may be a useful intraoperative adjunct to improve metastasectomy.
BACKGROUND: Complete pulmonary metastasectomy for sarcoma metastases provides patients an opportunity for long-term survival and possible cure. Intraoperative localization of preoperatively identified metastases and identification of occult lesions can be challenging. In this trial, we evaluated the efficacy of near-infrared (NIR) intraoperative imaging using second window indocyanine green during metastasectomy to identify known metastases and to detect occult nodules. METHODS: Thirty patients with pulmonary nodules suspicious for sarcoma metastases were enrolled in an open-label, feasibility study (NCT02280954). All patients received intravenous indocyanine green (5 mg/kg) 24 hours before metastasectomy. Patients 1 through 10 (cohort 1) underwent metastasectomy via thoracotomy to assess fluorescence patterns of nodules detected by traditional methods (preoperative imaging and intraoperative visualization/bimanual palpation). After confirming reliability within cohort 1, patients 11 through 30 (cohort 2) underwent video-assisted thoracic surgery metastasectomy with NIR imaging. RESULTS: In cohort 1, 14 out of 16 preoperatively identified pulmonary metastases (87.5%) displayed tumor fluorescence. Nonfluorescent metastases were deeper than fluorescent metastases (2.1 cm vs 1.3 cm; P = .03). Five out of 5 metastases identified during thoracotomy displayed fluorescence. NIR imaging identified 3 additional occult lesions in this cohort. In cohort 2, 33 out of 37 known pulmonary metastases (89.1%) displayed fluorescence. Nonfluorescent tumors were deeper than 2.0 cm (P = .007). NIR imaging identified 24 additional occult lesions. Of 24 occult lesions, 21 (87.5%) were confirmed metastases and the remaining 3 nodules were lymphoid aggregates. CONCLUSIONS: NIR intraoperative imaging with indocyanine green (5 mg/kg and 24 hours before surgery) localizes known sarcoma pulmonary metastases and identifies otherwise occult lesions. This approach may be a useful intraoperative adjunct to improve metastasectomy.
Authors: Thomas Schweiger; Stefan Schwarz; Denise Traxler; Philippe Dodier; Clemens Aigner; György Lang; Walter Klepetko; Konrad Hoetzenecker Journal: Ann Thorac Surg Date: 2016-02-22 Impact factor: 4.330
Authors: Naikhoba C O Munabi; Olushola B Olorunnipa; David Goltsman; Christine H Rohde; Jeffrey A Ascherman Journal: J Plast Reconstr Aesthet Surg Date: 2013-12-31 Impact factor: 2.740
Authors: John Y K Lee; Jayesh P Thawani; John Pierce; Ryan Zeh; Maria Martinez-Lage; Michelle Chanin; Ollin Venegas; Sarah Nims; Kim Learned; Jane Keating; Sunil Singhal Journal: Neurosurgery Date: 2016-12 Impact factor: 4.654
Authors: Jane Keating; Andrew Newton; Ollin Venegas; Sarah Nims; Ryan Zeh; Jarrod Predina; Charuhas Deshpande; John Kucharczuk; Shuming Nie; E James Delikatny; Sunil Singhal Journal: Ann Thorac Surg Date: 2016-10-25 Impact factor: 4.330
Authors: Neel P Chudgar; Murray F Brennan; Rodrigo R Munhoz; Peter R Bucciarelli; Kay See Tan; Sandra P D'Angelo; Manjit S Bains; Matthew Bott; James Huang; Bernard J Park; Valerie W Rusch; Prasad S Adusumilli; William D Tap; Samuel Singer; David R Jones Journal: J Thorac Cardiovasc Surg Date: 2017-03-21 Impact factor: 5.209
Authors: Olugbenga T Okusanya; David Holt; Daniel Heitjan; Charuhas Deshpande; Ollin Venegas; Jack Jiang; Ryan Judy; Elizabeth DeJesus; Brian Madajewski; Kenny Oh; May Wang; Steven M Albelda; Shuming Nie; Sunil Singhal Journal: Ann Thorac Surg Date: 2014-08-05 Impact factor: 4.330
Authors: Feredun Azari; Gregory T Kennedy; Kevin Zhang; Elizabeth Bernstein; Robert G Maki; Colleen Gaughan; Doraid Jarrar; Taine Pechet; John Kucharczuk; Sunil Singhal Journal: J Am Coll Surg Date: 2022-05-01 Impact factor: 6.532
Authors: Feredun Azari; Gregory Kennedy; Elizabeth Bernstein; Constantinos Hadjipanayis; Alexander Vahrmeijer; Barbara Smith; Eben Rosenthal; Baran Sumer; Jie Tian; Eric Henderson; Amy Lee; Quyen Nguyen; Summer Gibbs; Brian Pogue; Daniel Orringer; Cleopatra Charalampaki; Linda Martin; Janos Tanyi; Major Lee; John Y Lee; Sunil Singhal Journal: J Biomed Opt Date: 2021-05 Impact factor: 3.170
Authors: Pierre Bourgeois; Isabelle Veys; Danielle Noterman; Filip De Neubourg; Marie Chintinne; Sophie Vankerckhove; Jean-Marie Nogaret Journal: Front Oncol Date: 2021-03-09 Impact factor: 6.244
Authors: H M Schouw; L A Huisman; H H Boersma; S Kruijff; Y F Janssen; R H J A Slart; R J H Borra; A T M Willemsen; A H Brouwers; J M van Dijl; R A Dierckx; G M van Dam; W Szymanski Journal: Eur J Nucl Med Mol Imaging Date: 2021-10-11 Impact factor: 9.236
Authors: Thinzar M Lwin; Michael A Turner; Siamak Amirfakhri; Hiroto Nishino; Robert M Hoffman; Michael Bouvet Journal: Cells Date: 2022-01-12 Impact factor: 6.600
Authors: Marcus J Brookes; Corey D Chan; Fabio Nicoli; Timothy P Crowley; Kanishka M Ghosh; Thomas Beckingsale; Daniel Saleh; Petra Dildey; Sanjay Gupta; Maniram Ragbir; Kenneth S Rankin Journal: Cancers (Basel) Date: 2021-12-14 Impact factor: 6.639
Authors: Mohammed H A Alramdan; Ömer Kasalak; Lukas B Been; Albert J H Suurmeijer; Derya Yakar; Thomas C Kwee Journal: Skeletal Radiol Date: 2021-04-26 Impact factor: 2.199